Trenutni jezik:
- EN English
Partial refusal to give public access to Clinical Studies Reports relating to the approval of a medicinal product (Humira) for the treatment of Crohn's Disease
Primer odprt
Primer OI/3/2014/FOR - Preiskava uvedena dne Sreda | 16 april 2014 - Odločba z dne Sreda | 08 junij 2016 - Zadevna institucija ali organ Evropska agencija za zdravila ( Nadaljna preiskava ni utemeljena ) - Država Francija
Partial refusal to give public access to Clinical Studies Reports relating to the approval
of a medicinal product (Humira) for the treatment of Crohn's Disease